Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

计划入组 300 人 · 首次发布于 2018 年 7 月 27 日

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

计划入组 12 人 · 首次发布于 2009 年 7 月 27 日

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery

计划入组 16 人 · 首次发布于 2011 年 1 月 10 日

Brensocatib(BRINSUPRI)

C₂₃H₂₄N₄O₄ · Rx

TRC-8XXX

BI-1291583

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Insmed's Brensocatib NDA Accepted by FDA with Priority Review; Anticipated Launch in Q3 2025

Advancements in Neuroplastogens, KRAS G12C Inhibitors, and Other Therapies Highlighted by Recent Deals and Clinical Readouts

FDA Grants Priority Review to Brensocatib for Non-Cystic Fibrosis Bronchiectasis Treatment